Literature DB >> 17636430

S100A8/S100A9 and their association with cartilage and bone.

H Zreiqat1, C R Howlett, S Gronthos, D Hume, C L Geczy.   

Abstract

S100A8 and S100A9 are calcium-binding proteins expressed in myeloid cells and are markers of numerous inflammatory diseases in humans. S100A9 has been associated with dystrophic calcification in human atherosclerosis. Here we demonstrate S100A8 and S100A9 expression in murine and human bone and cartilage cells. Only S100A8 was seen in preosteogenic cells whereas osteoblasts had variable, but generally weak expression of both proteins. In keeping with their reported high-mRNA expression, S100A8 and S100A9 were prominent in osteoclasts. S100A8 was expressed in alkaline phosphatase-positive hypertrophic chondrocytes, but not in proliferating chondrocytes within the growth plate where the cartilaginous matrix was calcifying. S100A9 was only evident in the invading vascular osteogenic tissue penetrating the degenerating chondrocytic zone adjacent to the primary spongiosa, where S100A8 was also expressed. Whilst, S100A8 has been shown to be associated with osteoblast differentiation, both S100A8 and S100A9 may contribute to calcification of the cartilage matrix and its replacement with trabecular bone, and to regulation of redox in bone resorption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636430     DOI: 10.1007/s10735-007-9117-2

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   3.156


  45 in total

1.  Novel intra- and inter-molecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation.

Authors:  M J Raftery; Z Yang; S M Valenzuela; C L Geczy
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

2.  Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells.

Authors:  K Stewart; S Walsh; J Screen; C M Jefferiss; J Chainey; G R Jordan; J N Beresford
Journal:  J Bone Miner Res       Date:  1999-08       Impact factor: 6.741

Review 3.  The S100 family of multipurpose calcium-binding proteins.

Authors:  N S McNutt
Journal:  J Cutan Pathol       Date:  1998-11       Impact factor: 1.587

Review 4.  S100A8: emerging functions and regulation.

Authors:  R J Passey; K Xu; D A Hume; C L Geczy
Journal:  J Leukoc Biol       Date:  1999-10       Impact factor: 4.962

5.  A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo.

Authors:  R J Passey; E Williams; A M Lichanska; C Wells; S Hu; C L Geczy; M H Little; D A Hume
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

6.  S100A4: a novel negative regulator of mineralization and osteoblast differentiation.

Authors:  Wagner R Duarte; Tatsuya Shibata; Keizo Takenaga; Etsuko Takahashi; Kaori Kubota; Keiichi Ohya; Isao Ishikawa; Mitsuo Yamauchi; Shohei Kasugai
Journal:  J Bone Miner Res       Date:  2003-03       Impact factor: 6.741

7.  A novel technique for quantitative detection of mRNA expression in human bone derived cells cultured on biomaterials.

Authors:  H Zreiqat; B Markovic; W R Walsh; C R Howlett
Journal:  J Biomed Mater Res       Date:  1996

8.  Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro.

Authors:  Marie-Pierre Manitz; Basil Horst; Stephan Seeliger; Anke Strey; Boris V Skryabin; Matthias Gunzer; Werner Frings; Frank Schönlau; Johannes Roth; Clemens Sorg; Wolfgang Nacken
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

9.  Quantitative immunogold labeling of bone sialoprotein and osteopontin in methylmethacrylate-embedded rat bone.

Authors:  O Laboux; L-G Ste-Marie; F H Glorieux; A Nanci
Journal:  J Histochem Cytochem       Date:  2003-01       Impact factor: 2.479

Review 10.  The metastasis associated protein S100A4: role in tumour progression and metastasis.

Authors:  D M Helfman; E J Kim; E Lukanidin; M Grigorian
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

View more
  30 in total

Review 1.  S100 proteins in cartilage: role in arthritis.

Authors:  Raghunatha R Yammani
Journal:  Biochim Biophys Acta       Date:  2012-01-12

2.  Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.

Authors:  A Deguchi; T Tomita; U Ohto; K Takemura; A Kitao; S Akashi-Takamura; K Miyake; Y Maru
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

Review 3.  Calprotectin in rheumatic diseases.

Authors:  Francesca Ometto; Lara Friso; Davide Astorri; Costantino Botsios; Bernd Raffeiner; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

4.  Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma.

Authors:  Masahiko Fujiwara; Takeshi G Kashima; Akiko Kunita; Isao Kii; Daisuke Komura; Agamemnon E Grigoriadis; Akira Kudo; Hiroyuki Aburatani; Masashi Fukayama
Journal:  Tumour Biol       Date:  2011-03-01

5.  Expression of the Hutchinson-Gilford progeria mutation during osteoblast development results in loss of osteocytes, irregular mineralization, and poor biomechanical properties.

Authors:  Eva Schmidt; Ola Nilsson; Antti Koskela; Juha Tuukkanen; Claes Ohlsson; Björn Rozell; Maria Eriksson
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

6.  2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.

Authors:  Kelly A Fader; Rance Nault; Sandi Raehtz; Laura R McCabe; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2018-04-16       Impact factor: 4.219

7.  Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.

Authors:  A J Armstrong; M Häggman; W M Stadler; J R Gingrich; V Assikis; J Polikoff; J E Damber; L Belkoff; Ö Nordle; G Forsberg; M A Carducci; R Pili
Journal:  Clin Cancer Res       Date:  2013-11-19       Impact factor: 12.531

8.  Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

Authors:  L Endo-Munoz; A Cumming; S Sommerville; I Dickinson; N A Saunders
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

9.  Evaluating protein binding specificity of titanium surfaces through mass spectrometry-based proteomics.

Authors:  David Zuanazzi; Yizhi Xiao; Walter L Siqueira
Journal:  Clin Oral Investig       Date:  2020-09-01       Impact factor: 3.573

10.  S100A8 and S100A9 in experimental osteoarthritis.

Authors:  Hala Zreiqat; Daniele Belluoccio; Margaret M Smith; Richard Wilson; Lynn A Rowley; Katie Jones; Yogambha Ramaswamy; Thomas Vogl; Johannes Roth; John F Bateman; Christopher B Little
Journal:  Arthritis Res Ther       Date:  2010-01-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.